In vitro susceptibility of Leishmania infantum to artemisinin derivatives and selected trioxolanes

Cortes, S., Albuquerque, A. , Cabral, L. I. L., Lopes, L., Campino, L. and Cristiano, M. L.S. (2015) In vitro susceptibility of Leishmania infantum to artemisinin derivatives and selected trioxolanes. Antimicrobial Agents and Chemotherapy, 59(8), pp. 5032-5035. (doi: 10.1128/AAC.00298-15) (PMID:26014947) (PMCID:PMC4505222)

Full text not currently available from Enlighten.

Abstract

Leishmaniasis is among the world's most neglected diseases. Currently available drugs for treatment present drawbacks, urging the need for more effective, safer, and cheaper drugs. A small library of artemisinin-derived trioxanes and synthetic trioxolanes was tested against promastigote and intramacrophage amastigote forms of Leishmania infantum. The trioxolanes LC50 and LC95 presented the best activity and safety profiles, showing potential for further studies in the context of leishmanial therapy. Our results indicate that the compounds tested exhibit peroxide-dependent activity.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Albuquerque-Wendt, Ms Andreia
Authors: Cortes, S., Albuquerque, A., Cabral, L. I. L., Lopes, L., Campino, L., and Cristiano, M. L.S.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:Antimicrobial Agents and Chemotherapy
Publisher:American Society for Microbiology
ISSN:0066-4804
ISSN (Online):1098-6596
Published Online:26 May 2015

University Staff: Request a correction | Enlighten Editors: Update this record